Sheng Ma

Cimicifuga foetida L., Cimicifuga dahurica (Turcz.) Maxim., Cimicifuga heracleifolia Kom.

Also known as: Cimicifuga rhizome(English) 升麻(Chinese)

Shōma升麻 ショウマ(JP also admits Cimicifuga simplex) Seungma升麻 승마 Thăng ma(source gives Cimicifuga sp.)

Updated October 23, 2026 · Not yet clinically reviewed

Sheng Ma

Safety at a glance

Caution

5 recorded drug interactions, 2 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
releasing exterior
Temperature
Cool
Taste
Pungent,Sweet
Channels
Lung,Spleen,Stomach,Large Intestine

Functions

Releases the Exterior and Vents Rashes; Clears Heat and Resolves Toxicity; Lifts Sunken Qi

Traditional uses

Sheng Ma (black cohosh rhizome, cimicifuga) is a cool, acrid herb with a strongly ascending, lifting character. It releases the Exterior for Wind-Heat patterns and promotes the outward expression of rashes and measles at the early eruptive stage. As an ascending herb, it raises sinking Spleen Qi to address organ prolapse, chronic diarrhea, and hemorrhoids. It also clears Heat toxin from the head and throat, treating swollen and painful gums, sore throat, and mouth ulcers.

Western herbalism

Properties: anti-inflammatory

Pharmacological effects

  • Antipyretic: Oral C. dahurica extract (1 g/kg) or isoferulic acid (1–2 g/kg) lowered normal and vaccine-induced fever in rats; cimicifugoside similar.
  • Antiinflammatory and analgesic: Extract or isoferulic acid reduced carrageenin/dextran paw edema in rats; extract inhibited acetic acid writhing in mice at oral 1 and 5 g/kg; visamminol analgesic.
  • Smooth muscle: Visamminol inhibited acetylcholine-, histamine- and BaCl2-induced intestinal spasm; visamminol and visnagin had 30% and 10% of papaverine's spasmolytic activity.
  • Cardiovascular: Rhizome decreased heart rate and blood pressure; triterpenes from C. dahurica lowered cholesterol and triglycerides in hyperlipidemic rats.
  • Hepatoprotective: Methanolic extract and cimigenol 3-β-D-xylopyranoside prevented CCl4 liver disorder in mice.
  • Antimicrobial: Extract inhibited M. tuberculosis, staphylococci, P. aeruginosa and several dermatophyte fungi.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 102.

Formulas using this herb

39 of 39 formulas

Botanical

Cimicifuga foetida (along with the closely related C. dahurica and C. heracleifolia, which together supply the Chinese drug Sheng Ma) is a tall herbaceous perennial in the Ranunculaceae, native to mountainous regions of China, Mongolia, Korea and the Russian Far East. Plants grow 1-2 m tall from a stout, dark-coloured, branching rhizome with prominent stem scars. The large, two- to three-pinnately compound leaves are mostly basal and lower-cauline, with ovate, sharply serrate leaflets 5-10 cm long. From mid- to late summer the species produces tall, slender, often branched racemes or panicles of many small, malodorous, creamy-white flowers; the sepals are petaloid and quickly deciduous, and the showy parts are the dense tufts of white stamens, giving the inflorescence a feathery appearance. The fruits are clusters of follicles. Plants favour moist, humus-rich soils in cool, partly shaded mountain forest at 1,000-3,000 m elevation.

Family
Ranunculaceae
Pharmaceutical name
Rhizoma Cimicifugae
Parts used
rhizome
Plant type
herb
Native region
Hebei, Heilongjiang, Jilin, Liaoning, Qinghai, Shaanxi, Shanxi, Sichuan, Yunnan

Constituents

Isoferulic acid

Hydroxycinnamic acid (phenylpropanoid) · The single quality-control marker of the Chinese Pharmacopoeia monograph for Cimicifugae Rhizoma: not less than 0.10 percent of the dried drug

Isoferulic acid is anti-inflammatory and antipyretic and is the compound the Pharmacopoeia uses to certify Sheng Ma. Zhang et al. (2024) argue this single-marker standard is inadequate for a drug containing 348 identified compounds and three permitted source species, and propose a multi-marker standard adding ferulic acid, caffeic acid and cimifugin.

Cycloartane (9,19-cyclolanostane) triterpene glycosides

Triterpenoid saponin · The largest constituent class: 211 of the 348 compounds catalogued for Cimicifugae Rhizoma, about 60 percent of the identified chemistry

The structural signature of the genus, typically glycosylated at C-3. Individual members from Cimicifuga foetida - cimicifoetisides A and B, cimiaceroside C, the cimifosides and the newly described 9,10-seco cimibiosides - are cytotoxic to cancer cell lines and inhibit Wnt signalling in vitro. They are also the fraction most likely to carry the genus' hepatic liability, since the hepatotoxic fibrous-root extract studied by Yu et al. (2022) was saponin- and phenolic acid-rich.

Cimifugin and norcimifugin

Chromone · Minor class: 10 chromones among the 348 catalogued compounds; proposed as an additional quality marker

Cimifugin and its glucoside occur across the Asian Cimicifuga species and are largely absent from the American black cohosh, so they are part of the chemical evidence that these are different drugs. Cimifugin from Cimicifuga foetida binds the acetylcholinesterase active site in affinity-ultrafiltration screening.

Ferulic acid and caffeic acid

Hydroxycinnamic acid (phenylpropanoid) · Among the 67 phenylpropanoids catalogued for the drug; routinely quantified alongside isoferulic acid

Caffeic acid is the compound Liu et al. (2025) identified as the SARS-CoV-2 entry-blocking constituent of a Cimicifuga foetida water extract, active against both wild-type and JN.1 pseudoparticles. Both acids also bind acetylcholinesterase in vitro. Neither is specific to the genus, so neither authenticates the drug.

Fukinolic acid, fukiic acid and the cimicifugic acids

Hydroxycinnamic acid esters (phenylpropanoid esters) · Characteristic ester fraction; the specific profile differs between Asian and American species and is used chemometrically to tell them apart

These polyphenolic esters are the basis of the HPLC plus principal component analysis methods that separate Asian Cimicifuga (sheng ma) from Actaea racemosa and from Appalachian bugbane. Their practical importance is forensic rather than therapeutic: they are how a laboratory establishes which species is actually in a product.

Feruloyl dopamine, feruloyl methyldopamine and feruloyl tyramine O-hexosides

Hydroxycinnamic acid amide glycoside · Trace marker compounds; three feruloyl dopamine-O-hexoside isomers plus a dihexoside give 100 percent species discrimination in validated chemometric models

Geng et al. (2017) showed that isomers of feruloyl methyldopamine 4-O-hexoside and feruloyl tyramine 4-O-hexoside drive the separation of the Asian species Actaea foetida and A. dahurica from black cohosh in principal component analysis. These are the most reliable published chemical markers for distinguishing this drug from Actaea racemosa.

Higenamine and coclaurine

Benzylisoquinoline alkaloid · Trace; newly confirmed in Cimicifuga rhizome by LC-MS/MS, lateral flow immunoassay and ELISA across a 128-product Kampo survey (Sakamoto et al., 2025)

Higenamine is a beta-2 adrenergic agonist and has been on the World Anti-Doping Agency prohibited list since 2017. Coclaurine is not itself prohibited but is metabolised to higenamine in human liver microsomes and produced urinary higenamine in mice. Cimicifuga rhizome was newly identified as containing both. This is a real, testable consequence of taking Sheng Ma, and it is not mentioned in any traditional source.

Polysaccharides

Heteropolysaccharide (mannose, glucose, galactose, arabinose) · Bulk water-extractable fraction; the purified subfraction SM05 has been characterised from Cimicifuga foetida

A Cimicifuga foetida polysaccharide activated Nrf2/Keap1, suppressed NLRP3-driven pyroptosis and shifted gut microbiota in mice with dextran sodium sulfate colitis. Relevant because polysaccharides are extracted by decoction, the way the drug is actually used, unlike the alcohol-extracted saponins most pharmacology papers study.

Drug interactions

World Anti-Doping Agency prohibited substances - higenamine (beta-2 agonist) - in competitive athletes

Major · Anti-doping rule violation; higenamine is prohibited at all times · Evidence level: Probable

Sakamoto et al. (2025) analysed 128 Kampo extract products and newly confirmed Cimicifuga rhizome as containing both higenamine, a WADA-prohibited beta-2 agonist, and coclaurine, which human liver microsomes convert to higenamine and which produced urinary higenamine excretion in mice. Sheng Ma appears in widely used formulas such as Sheng Ma Ge Gen Tang and Bu Zhong Yi Qi Tang, so the exposure route is ordinary prescribing, not supplementation. What has not been established is the urinary concentration a therapeutic dose produces in humans, so the size of the risk is unquantified.

Clinical note: Do not prescribe Sheng Ma or Sheng Ma-containing formulas to athletes subject to anti-doping testing without checking the current WADA list and the athlete's testing obligations. A negative product label is not reassurance: higenamine here is an intrinsic plant constituent, not an adulterant.

Actaea racemosa (black cohosh) menopause products adulterated with Asian Cimicifuga species

Major · Wrong species dispensed, with a possible hepatic consequence · Evidence level: Probable

This runs in the opposite direction to most substitutions in this database: sheng ma species are the adulterant of a Western drug. Asian Cimicifuga species including C. foetida, C. heracleifolia and C. dahurica are documented adulterants in the global black cohosh market, and Yu et al. (2022) report that market black cohosh material was adulterated with Asian cohosh with the fibrous roots not removed. Analyses of black cohosh products implicated in hepatotoxicity reports found phytochemical profiles inconsistent with authentic Actaea racemosa. The hypothesis that some black cohosh liver injury is actually Asian Cimicifuga injury is plausible and not proven - the assays that would settle it were done on the products, not on patients.

Clinical note: Do not treat black cohosh clinical data as evidence about Sheng Ma, or the reverse. If a patient on a black cohosh menopause product develops abnormal liver enzymes, species-authenticate the product rather than assuming Actaea racemosa. Feruloyl dopamine-O-hexoside profiling or DNA methods can do this.

Hepatotoxic drugs and pre-existing liver disease

Moderate · Additive hepatic risk, species- and plant-part-dependent · Evidence level: Possible

The hepatic signal in this genus is real but is attached to specific species and to a specific plant part. Yu et al. (2022) separated rhizome from fibrous root in Cimicifuga dahurica: fibrous root extract was slightly more cytotoxic to L-02 hepatocytes (IC50 1.26 versus 1.417 mg/mL) and, over 90 days of sub-chronic dosing, raised white cells, ALP, ALT, AST, bilirubin and cholesterol, produced granular and ballooning degeneration on histology, and increased nuclear p-NF-kappaB dose-dependently. Cimicifuga heracleifolia raised serum ALT and liver weights in female rats. Neither species is C. foetida, and neither result is a human observation; the human hepatotoxicity literature that everyone cites is for Actaea racemosa, a fourth species that is not Sheng Ma at all.

Clinical note: Buy rhizome with the fibrous roots removed, as the Pharmacopoeia processing requires, since the fibrous root is where the animal toxicity concentrated. Avoid prolonged high-dose use in patients with liver disease or on hepatotoxic drugs, and check liver enzymes if a course runs beyond a few weeks. Say to the patient which species they are taking.

Cisplatin and other cytotoxic chemotherapy

Moderate · Unpredictable potentiation of cytotoxicity · Evidence level: Theoretical

Total glycosides of Cimicifuga dahurica combined with cisplatin gave combination index values below 0.8 (synergy) in HCT-8 colon cancer cells and reduced tumour weight by about 86 percent versus 65 percent for cisplatin alone in H22-bearing mice, acting through JNK and p38 MAPK activation and caspase-dependent apoptosis. Enhanced tumour kill in mice is not evidence of safety in patients, and the same pathways are the ones that mediate chemotherapy toxicity in normal tissue.

Clinical note: Do not add Sheng Ma to an active cytotoxic chemotherapy regimen on the strength of preclinical synergy data. If a patient is already taking it, tell the oncology team rather than silently continuing.

Hormone therapy, tamoxifen and other endocrine treatments

Minor · Uncertain; the risk is that black cohosh assumptions are imported into this drug · Evidence level: Theoretical

Almost all the menopause and endocrine literature belongs to Actaea racemosa, not to Cimicifuga foetida. The Cochrane review of black cohosh (Leach and Moore, 2012) found no significant difference from placebo in hot flush frequency across 16 trials and 2,027 women. For the Chinese species the human evidence is thin and mostly Chinese-language: Zhang et al. (2024) report a triterpenoid saponin preparation that improved menopausal symptoms without changing hormone levels or endometrial thickness, and a 96-woman study of C. foetida for menopausal breast pain. There is no established oestrogen-receptor mechanism to underpin an interaction, and no interaction study.

Clinical note: Do not counsel a patient about Sheng Ma using black cohosh's oestrogen-related cautions, and do not offer it as a menopause treatment on black cohosh's reputation - which the Cochrane review does not support in any case. Where a patient with a hormone-sensitive cancer is involved, discuss with the treating team rather than reasoning from the wrong species.

Dosage

FormAmountFrequencyNotes
decoction3–10 gDaily
中国药典 2020 【用法与用量】3~10g。 【性味与归经】辛、微甘,微寒。归肺、脾、胃、大肠经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Sheng Ma + Chai Hu柴胡

The pair raises the clear yang and lifts sunken middle qi, assisting qi tonics to treat prolapse.

Sinking of middle qi: prolapse, chronic diarrhea, fatigue.

Named pairing — Zhongyaoxue national textbook; used together in Bu Zhong Yi Qi Tang (Li Dongyuan)

Sheng Ma + Ge Gen葛根

Both release the muscle layer and vent; together they bring out incompletely expressed rashes.

Early measles with rashes that fail to erupt fully.

Core pair of a classical formula — Sheng Ma Ge Gen Tang, Yan Shi Xiao Er Fang Lun

Sheng Ma + Huang Lian黄连

Bitter cold clearing is combined with upward venting, so stomach fire is drained while constrained fire is dispersed rather than trapped.

Stomach fire with toothache, gum swelling and bleeding.

Core pair of a classical formula — Qing Wei San, Pi Wei Lun (Li Dongyuan)

Evidence

Study design on record, not certainty of outcome.

Systematic review / meta-analysis
1
In vitro / animal
5
Other / unclassified
1

Black cohosh (Cimicifuga spp.) for menopausal symptoms

Leach MJ, Moore V · Cochrane Database of Systematic Reviews · 2012 · systematic review

Systematic review / meta-analysis · Not yet verified

Included here as the contrast, not as evidence about Sheng Ma. Sixteen randomised trials in 2,027 perimenopausal and postmenopausal women, all using oral monopreparations of black cohosh at a median 40 mg daily for a mean 23 weeks, compared with placebo, hormone therapy, red clover or fluoxetine. There was no significant difference from placebo in hot flush frequency. Every trial used Cimicifuga racemosa (Actaea racemosa), the North American species, which is NOT one of the three species the Chinese Pharmacopoeia recognises as Sheng Ma. Nearly the entire menopause and hepatotoxicity literature for the genus sits here, and none of it transfers to Cimicifuga foetida.

doi:10.1002/14651858.CD007244.pub2

Fibrous Roots of Cimicifuga Are at Risk of Hepatotoxicity

Yu Y, Tan J, Nie J, Lv C, Lu J · Molecules · 2022 · animal

In vitro / animal · Not yet verified

Motivated by the finding that market black cohosh was adulterated with Asian Cimicifuga whose fibrous roots had not been removed, this study separated rhizome from fibrous root in Cimicifuga dahurica, extracted both with 70 percent ethanol and identified 39 compounds (chiefly saponins and phenolic acids). Fibrous root extract was more cytotoxic to L-02 hepatocytes than rhizome (IC50 1.26 versus 1.417 mg/mL), and in a 90-day sub-chronic study it significantly raised white cells, ALP, ALT, AST, bilirubin and cholesterol, caused extensive granular and ballooning degeneration in liver tissue, and raised nuclear p-NF-kappaB dose-dependently. The species is C. dahurica, one of the three official Sheng Ma species but not C. foetida, and the finding is about a plant part the Pharmacopoeia already says to remove.

doi:10.3390/molecules27030938

Metabolism of coclaurine into the WADA-banned substance higenamine: a doping-relevant analytical evaluation of Kampo extracts

Sakamoto S, Osaki K, Abe H, Tayama Y, Tsuruta A, Nuntawong P, Koyanagi S, Yodsurang V, Morimoto S · Journal of Natural Medicines · 2025 · animal

In vitro / animal · Not yet verified

Combined mouse excretion study, human liver microsome incubation and analytical survey of 128 Kampo extract products by lateral flow immunoassay, ELISA and LC-MS/MS. Coclaurine administration produced urinary higenamine in mice and higenamine formation in human liver microsomes. Cimicifuga rhizome was newly confirmed to contain higenamine, and also newly identified as containing coclaurine - one of only six and nine crude drugs respectively in that position. Higenamine has been WADA-prohibited since 2017. The study quantifies the drugs, not the urinary levels a therapeutic human dose would produce, so it establishes the hazard without sizing the risk.

doi:10.1007/s11418-025-01940-4

Screening of Medicinal Herbs Identifies Cimicifuga foetida and Its Bioactive Component Caffeic Acid as SARS-CoV-2 Entry Inhibitors

Liu CH, Kuo YT, Lin CJ, Yen FL, Wu SJ, Lin LT · Viruses · 2025 · in vitro

In vitro / animal · Not yet verified

Pseudoparticle-based screen of heat-clearing herbs and formulas for SARS-CoV-2 entry inhibition. The water extract of Cimicifuga foetida rhizome - the species this monograph describes, and prepared the way the drug is actually decocted - was the most potent of those tested, and caffeic acid was identified as the active component, blocking entry of both wild-type and JN.1 pseudoparticles and inactivating the particles directly. Sheng Ma Ge Gen Tang, the classical formula built on this herb, was also active. This is cell-culture work with pseudoparticles, not live virus and not patients.

doi:10.3390/v17081086

Cimicifuga foetida L. polysaccharide alleviates ulcerative colitis by inhibiting pyroptosis and regulating gut microbiota

Luo Q, Xu Y, Li Z, Wang X, Cao L, Dong G, Guo S, Dai W · Frontiers in Pharmacology · 2026 · animal

In vitro / animal · Not yet verified

A purified Cimicifuga foetida polysaccharide (SM05, composed of mannose, glucose, galactose and arabinose) reduced disease activity index, colon shortening and histological injury in dextran sodium sulfate colitis in mice, activating Nrf2/Keap1, suppressing NLRP3-dependent pyroptosis, preserving tight junction proteins and shifting the microbiota away from Bacteroides and Desulfovibrio towards Akkermansia. Species-specific to C. foetida and uses the water-extractable fraction, but it is a purified single fraction in a chemical colitis model, not the crude drug in patients.

doi:10.3389/fphar.2026.1780518

Comprehensive Profiling of Acetylcholinesterase Inhibitors From Cimicifuga foetida Using Activity-Oriented Offline Preparation Technology

Zhou Y, Liu Q, Liu X, Li S, Shi D, Zhang Y · Chemistry & Biodiversity · 2026 · in vitro

In vitro / animal · Not yet verified

Affinity-ultrafiltration mass spectrometry with molecular docking, enzyme kinetics and network pharmacology identified cimifugin, cimifugoside, caffeic acid, ferulic acid and isoferulic acid from Cimicifuga foetida as acetylcholinesterase active-site binders. Useful as a chemical map of the species, but binding affinity in a screening assay is a long way from an anti-Alzheimer effect, and the authors do not claim otherwise.

doi:10.1002/cbdv.202503515

Traditional uses, phytochemistry, pharmacology, quality control and clinical studies of Cimicifugae Rhizoma: a comprehensive review

Zhang Q, Wei W, Jin X, Lu J, Chen S, Ogaji OD, Wang S, Du K, Chang Y, Li J · Chinese Medicine · 2024 · systematic review

Other / unclassified · Verified

The most complete review of Sheng Ma as the Chinese Pharmacopoeia defines it - the dried rhizome of Cimicifuga foetida, C. dahurica and C. heracleifolia, explicitly not Actaea racemosa. It catalogues 348 compounds (211 triterpenoid saponins, 67 phenylpropanoids, 10 chromones, 7 alkaloids), records isoferulic acid as the sole Pharmacopoeia marker at not less than 0.10 percent and argues for a multi-marker standard. Its clinical section is short and revealing: a Cimicifuga triterpenoid saponin tablet that improved menopausal symptoms without changing hormone levels or endometrial thickness, C. foetida with adefovir in 60 chronic hepatitis B patients, C. foetida for menopausal breast pain in 96 women, and multi-herb Sheng Ma decoctions for herpes zoster, oral ulcers and lupus. These are small, largely Chinese-language, and mostly not blinded. Its toxicity section attaches hepatic findings to C. dahurica and C. heracleifolia, not to C. foetida, and notes that the human adverse-reaction reports concern black cohosh.

doi:10.1186/s13020-024-00937-7

Safety

Contraindications

It is not suitable for patients with measles with adequate eruption, vigorous fire due to yin deficiencyand yang hyperactivity.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 26–31.

Side effects

  • Often causes vomiting through gastric irritation.
  • Overdosage may cause acratia, vertigo, tremor, headache, slow pulse and collapse.
  • Toxic doses cause heart inhibition, hypotension and death from respiratory paralysis.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 102.

Cultural and historical

Shen Nong Ben Cao Jing (Divine Husbandman's Classic of Materia Medica) · Han dynasty, c. 200 CE

Sheng Ma enters the materia medica in the upper class of drugs, used to resolve toxicity and treat epidemic pestilential qi. Its use as an antipyretic and analgesic dates from here. Every classical statement about Sheng Ma refers to the Chinese Cimicifuga species; black cohosh was unknown in China until the modern era.

Shang Han Lun (Treatise on Cold Damage), Zhang Zhongjing · Eastern Han dynasty, c. 220 CE

Source of Ma Huang Sheng Ma Tang. The earliest formula use fixes Sheng Ma as a venting and toxicity-resolving herb in febrile disease, not as a gynaecological or endocrine agent.

Pi Wei Lun (Treatise on the Spleen and Stomach), Li Dongyuan · Jin-Yuan period, 1249

Source of Bu Zhong Yi Qi Tang, in which Sheng Ma is paired with Chai Hu in small dose to raise sunken yang qi for prolapse of the rectum or uterus. This lifting action is the third and most distinctively Chinese of the herb's functions and has no counterpart in the Western black cohosh tradition.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1596

Consolidates the three functions still listed today - venting rashes, clearing heat and resolving toxicity, and lifting sunken qi - and describes the drug's characteristic fetid odour, which gives Cimicifuga foetida its species epithet and remains a practical identity check.

References

  1. Bittner M, Schenk R, Springer A, Melzig MF. Economical, Plain, and Rapid Authentication of Actaea racemosa L. (syn. Cimicifuga racemosa, Black Cohosh) Herbal Raw Material by Resilient RP-PDA-HPLC and Chemometric Analysis. Phytochemical Analysis. 2016 doi:10.1002/pca.2622
  2. Geng P, Harnly JM, Sun J, Zhang M, Chen P. Feruloyl dopamine-O-hexosides are efficient marker compounds as orthogonal validation for authentication of black cohosh (Actaea racemosa)—an UHPLC-HRAM-MS chemometrics study. Analytical and Bioanalytical Chemistry. 2017 doi:10.1007/s00216-017-0205-1
  3. Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety assessment. Toxicology and Applied Pharmacology. 2010 doi:10.1016/j.taap.2009.12.005
  4. Lim TY, Considine A, Quaglia A, Shawcross DL. Subacute liver failure secondary to black cohosh leading to liver transplantation. BMJ Case Reports. 2013 doi:10.1136/bcr-2013-009325
  5. Zhang LL, Si JY, Zhang LJ, Xiao-Wei H, Lin L, Li RY, Chen D, Cao L. Synergistic anti-tumor activity and mechanisms of total glycosides from Cimicifuga dahurica in combination with cisplatin. Chinese Journal of Integrative Medicine. 2016 doi:10.1007/s11655-015-2108-3
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice